Verista: Quality, Compliance and Safety Across the Entire Drug Development Continuum

The COVID-19 pandemic has created huge ripples across all industries worldwide. In the life sciences industry particularly, we have seen drugs being delivered to market in record time. In fact, we have proven that the industry can get an mRNA vaccine successfully launched in ten months as opposed to years. In addition to the enormous pressure of getting safe and effective drugs to the market in the shortest possible time, life science companies must also ensure that they comply with the onerous complexities of all the regulations from R&D to manufacturing. Failure to carry out proper validation, compliance, and regulatory activities can lead to potentially disastrous results. Verista is a pioneer in this field, partnering with clients to facilitate compliance and safety across the entire product development continuum. The company provides operational, IT and validation expertise across systems, quality, and data integrity to fast track the drug development process.

Verista sits at the intersection of validation, compliance, quality and regulatory – managing and overseeing the complex aspects of business operations, processes and data integrity associated with these functions. In fact, the company validates and automates operational data from R&D to the manufacturing floor. At the same time, this data needs to be collated for regulatory compliance and the advancement of the product lifecycle. The company’s deep domain expertise enables clients to adhere to regulations at every stage of the drug development lifecycle with the greatest precision, safety, and quality. “We use innovative technology to ensure that our clients’ systems are highly compliant while maintaining data integrity at all levels,” says Manny Soman, CEO, Verista. Having said that, Verista empowers clients to improve operations, enhance quality, reduce risks, and ultimately improve patients’ lives.

Recently, Verista worked with four COVID-19 vaccine manufacturers to help bring their therapies to market in the shortest time possible.